<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548947</url>
  </required_header>
  <id_info>
    <org_study_id>20.111</org_study_id>
    <nct_id>NCT04548947</nct_id>
  </id_info>
  <brief_title>Does Routine Submucosal Injection Improve Complete Resection of 4-20 mm Neoplastic Colorectal Polyps?</brief_title>
  <official_title>Does Routine Submucosal Injection Improve Complete Resection of 4-20 mm Neoplastic Colorectal Polyps?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-endoscopist, single center, clinical study at tertiary referral&#xD;
      center that addresses an important current challenge in the prevention of colorectal cancer&#xD;
      (CRC), namely, how to improve the complete removal of CRC precursors. This study will observe&#xD;
      the potential benefit of specific polypectomy technique in conjunction with a systematic&#xD;
      submucosal injection prior to the polyp resection. This study will evaluate the completeness&#xD;
      and incompleteness of the resection of colorectal neoplastic polyps during the procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-detection and incomplete resection of neoplastic colorectal polyps have been identified&#xD;
      as the main risk factors for the development of CRC in patients after a colonoscopy. Between&#xD;
      7% and 9% of all newly diagnosed CRCs are estimated to be such &quot;interval cancers,&quot; occurring&#xD;
      after a previous colonoscopy and before the next surveillance examination. The vast majority&#xD;
      of interval cancers are caused by incomplete detection or resection during colonoscopy&#xD;
      examination. The contribution of incomplete resection towards interval cancer has recently&#xD;
      been pointed out by a panel of experts as one of the cornerstones of CRC prevention that need&#xD;
      to be addressed in future research studies. The primary aim of this study is to examine the&#xD;
      incomplete adenoma resection rates when performing a cold snare polypectomy in conjunction&#xD;
      with a submucosal injection for endoscopic resection of 4-20 mm non-pedunculated colorectal&#xD;
      polyps. The subjects are patients, men and women, aged between 45-80 years old that are&#xD;
      scheduled for a colonoscopy. The secondary aims are to identify procedure-related&#xD;
      complication rates and patient-, polyp-, and endoscopist-related factors associated with&#xD;
      incomplete adenoma resection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 12, 2021</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incomplete resection rate (IRR)</measure>
    <time_frame>Day 1</time_frame>
    <description>The number of incomplete polyps resected after polypectomy, as defined by any neoplastic tissue found in marginal biopsies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immediate bleeding complications</measure>
    <time_frame>Day 1</time_frame>
    <description>bleeding requiring endoscopic intervention either during colonoscopy/polypectomy, or requiring an immediate second intervention such as surgery and/or hospital admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed bleeding complications</measure>
    <time_frame>14 days after the initial procedure</time_frame>
    <description>bleeding after the end of the initial procedure 14 days later</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other severe complications</measure>
    <time_frame>14 days after the initial procedure</time_frame>
    <description>Post-polypectomy syndrome and perforation requiring endoscopic intervention and/or surgery, and/or hospital admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of polyps considered interpretable for complete polyp removal</measure>
    <time_frame>14 days after the initial procedure</time_frame>
    <description>Proportion of polyps considered interpretable for complete polyp removal</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">435</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Cold snare polypectomy with a submucosal injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The procedure will include a cold snare polypectomy with a submucosal injection done prior to the resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cold snare polypectomy in conjunction with a submucosal injection</intervention_name>
    <description>The cold snare polypectomy in conjunction with a submucosal injection is a procedure during which the endoscopist resects the colorectal polyps during a colonoscopy, without any electrocautery.</description>
    <arm_group_label>Cold snare polypectomy with a submucosal injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed consent form; aged 45-80 years old, indication to undergo a colonoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known inflammatory bowel disease; active colitis; coagulopathy; familial polyposis&#xD;
             syndrome; poor general health, defined as an American Society of Anesthesiologists&#xD;
             (ASA) physical status class &gt;3; emergency colonoscopies, hospitalized patients or&#xD;
             patients referred from the emergency room.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maureen Fontaine</last_name>
    <phone>(514) 890-8000</phone>
    <phone_ext>30655</phone_ext>
    <email>maureen.fontaine.chum@ssss.gouv.qc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen Fontaine</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>30655</phone_ext>
      <email>maureen.fontaine.chum@ssss.gouv.qc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Daniel von Renteln, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Daniel von Renteln, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Bouchard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik Deslandres, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mickael Bouin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey Weber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colorectal cancer</keyword>
  <keyword>incomplete resection rate</keyword>
  <keyword>submucosal injection</keyword>
  <keyword>neoplastic polyps</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

